View in EDS HTML Full Text PDF Full Text

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29 , 9891–9895"

Saved in:
Bibliographic Details
Title: Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29 , 9891–9895"
Authors: Rayson, Daniel1 (AUTHOR) daniel.rayson@nshealth.ca, Gandhi, Sonal2 (AUTHOR), Joy, Anil A.3 (AUTHOR), Brezden-Masley, Christine4 (AUTHOR), Gelmon, Karen A.5 (AUTHOR), Sehdev, Sandeep6 (AUTHOR), Cescon, David7 (AUTHOR), Chia, Stephen5 (AUTHOR)
Source: Current Oncology. May2023, Vol. 30 Issue 5, p5050-5053. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 163940469
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29 , 9891–9895"
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Rayson%2C+Daniel%22">Rayson, Daniel</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> daniel.rayson@nshealth.ca</i><br /><searchLink fieldCode="AR" term="%22Gandhi%2C+Sonal%22">Gandhi, Sonal</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Joy%2C+Anil+A%2E%22">Joy, Anil A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brezden-Masley%2C+Christine%22">Brezden-Masley, Christine</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gelmon%2C+Karen+A%2E%22">Gelmon, Karen A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sehdev%2C+Sandeep%22">Sehdev, Sandeep</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cescon%2C+David%22">Cescon, David</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chia%2C+Stephen%22">Chia, Stephen</searchLink><relatesTo>5</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Current+Oncology%22">Current Oncology</searchLink>. May2023, Vol. 30 Issue 5, p5050-5053. 4p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=163940469
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/curroncol30050381
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 5050
    Titles:
      – TitleFull: Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29 , 9891–9895"
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rayson, Daniel
      – PersonEntity:
          Name:
            NameFull: Gandhi, Sonal
      – PersonEntity:
          Name:
            NameFull: Joy, Anil A.
      – PersonEntity:
          Name:
            NameFull: Brezden-Masley, Christine
      – PersonEntity:
          Name:
            NameFull: Gelmon, Karen A.
      – PersonEntity:
          Name:
            NameFull: Sehdev, Sandeep
      – PersonEntity:
          Name:
            NameFull: Cescon, David
      – PersonEntity:
          Name:
            NameFull: Chia, Stephen
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 11980052
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Current Oncology
              Type: main
ResultId 1